Taking GLP-1 drugs is a viable decision for some individuals, such as Charles Barkley, who struggle significantly with weight.

“It's almost certainly using the GLP-1.”

GLP-1 agonists are useful for individuals unable to make lifestyle changes, but they carry risks, including potential lifelong dependency and negative effects on the brain's pleasure pathways.

“So, for someone like Charles Barkley, great example, probably on balance, these are positive if he can't make lifestyle changes, but what about the millions of young men who are at 15% body fat and could just eat single-ingredient foods, but are going to take retatrutide”